DPP4 and atherosclerosis: Furthermore, several studies demonstrated that DPP-4 inhibitors prevented increase in carotid intima-media thickness (IMT), an established marker of early-stage atherosclerosis [16–19], in patients with type 2 diabetes (T2DM) compared with conventional treatment [20–22].